Fumagillin, a new P-glycoprotein-interfering agent able to modulate moxidectin efflux in rat hepatocytes

Journal of Veterinary Pharmacology and Therapeutics

Volumn 29, Issue 6, 2006, Pages 489-494

  Dupuy, J ^a,b   Lespine, A ^b   Sutra, J F ^b   Alvinerie, M ^b  

^a CEMAGREF   (France)

^b Lab de Pharmacologie Toxicologie   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DIMINAZENE ACETURATE; FUMAGILLIN; GLYCOPROTEIN P INHIBITOR; IVERMECTIN; MOXIDECTIN; MULTIDRUG RESISTANCE PROTEIN 1; RHODAMINE 123; VALSPODAR;

ANIMAL CELL; AREA UNDER THE CURVE; ARTICLE; CELL CULTURE; CELL LEVEL; CONTROLLED STUDY; DRUG EFFECT; DRUG PROTEIN BINDING; DRUG TRANSPORT; DRUG UPTAKE; EPITHELIUM CELL; GENETIC TRANSFECTION; KIDNEY EPITHELIUM; LIVER CELL; NONHUMAN; PHARMACODYNAMICS; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT;

ANIMALS; ANTHELMINTICS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; CELLS, CULTURED; CYCLOHEXANES; DRUG INTERACTIONS; FATTY ACIDS, UNSATURATED; HEPATOCYTES; MACROLIDES; MICE; P-GLYCOPROTEIN; RATS; SESQUITERPENES; SWINE;

MURINAE; SUIDAE;

EID: 33750578882     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2006.00780.x     Document Type: Article

References (30)

1. Alvinerie, M., Dupuy, J., Eeckhoutte, C. & Sutra, J.F. (1999) Enhanced absorption of pour-on ivermectin formulation in rats by co- administration of the multidrug-resistant-reversing agent verapamil. Parasitology Research, 85, 920-922.
2. Atsriku, C., Watson, D.G., Grant, M.H. & Skellern, G.G. (2003) The effect of inducing agents on the metabolism of trypanocidal diamidines by isolated rat hepatocytes. Chemico-Biological Interactions, 146, 297-305.
3. Ballent, M., Lifschitz, A., Virkel, G., Sallovitz, J. & Lanusse, C. (2006) Modulation of the P-glycoprotein-mediated intestinal secretion of ivermectin: in vitro and in vivo assessments. Drug Metabolism and Disposition, 34, 457-463.
4. Bray, P.G., Barrett, M.P., Ward, S.A. & de Koning, H.P. (2003) Pentamidine uptake and resistance in pathogenic protozoa: past, present and future. Trends in Parasitology, 19, 232-239.
5. Dupuy, J., Larrieu, G., Sutra, J.F., Eeckhoutte, C. & Alvinerie, M. (2001) Influence of verapamil on the efflux and metabolism of 14C moxidectin in cultured rat hepatocytes. Journal of Veterinary Pharmacology and Therapeutics, 24, 171-177.
6. Dupuy, J., Larrieu, G., Sutra, J.F., Lespine, A. & Alvinerie, M. (2003) Enhancement of moxidectin bioavailability in lamb by a natural flavonoid: quercetin. Veterinary Parasitology, 112, 337-347.
7. Dupuy, J., Lespine, A., Sutra, J.F. & Alvinerie, M. (2006) The interaction between moxidectin and MDR transporters in primary cultures of rat hepatocytes. Journal of Veterinary Pharmacology and Therapeutics, 29, 107-111.
8. Geary, T.G., Sangster, N.C. & Thompson, D.P. (1999) Frontiers in anthelmintic pharmacology. Veterinary Parasitology, 84, 275-295.
9. Gibaldi, M. & Perrier, D. (1982) Pharmacokinetics. Marcel Dekker Inc., New York.
10. Guyonnet, J., Richard, M. & Hellings, P. (1995) Determination of fumagillin in muscle tissue of rainbow trout using automated ionpairing liquid chromatography. Journal of Chromatography. B, Biomedical Applications, 666, 354-359.
11. Hamada, A., Miyano, H., Watanabe, H. & Saito, H. (2003) Interaction of imatinib mesilate with human P-glycoprotein. Journal of Pharmacology and Experimental Therapeutics, 307, 824-828.
12. Hirsch-Ernst, K.I., Ziemann, C., Foth, H., Kozian, D., Schmitz-Salue, C. & Kahl, G.F. (1998) Induction of mdr1b mRNA and P-glycoprotein expression by tumor necrosis factor alpha in primary rat hepatocyte cultures. Journal of Cellular Physiology, 176, 506-515.
13. Hirsch-Ernst, K.I., Ziemann, C., Rustenbeck, I. & Kahl, G.F. (2001) Inhibitors of mdr1-dependent transport activity delay accumulation of the mdr1 substrate rhodamine 123 in primary rat hepatocyte cultures. Toxicology, 167, 47-57.
14. Kamisako, T., Gabazza, E.C., Ishihara, T. & Adachi, Y. (1999) Molecular aspects of organic compound transport across the plasma membrane of hepatocytes. Journal of Gastroenterology and Hepatology, 14, 405-412.
15. de Koning, H.P. (2001) Transporters in African trypanosomes: role in drug action and resistance. International Journal for Parasitology, 31, 512-522.
16. Korystov, Y.N., Ermakova, N.V., Kublik, L.N., Levitman, M., Shaposhnikova, V.V., Mosin, V.A., Drinyaev, V.A., Kruglyak, E.B., Novik, T.S. & Sterlina, T.S. (2004) Avermectins inhibit multidrug resistance of tumor cells. European Journal of Pharmacology, 493, 57-64.
17. Laffont, C.M., Toutain, P.L., Alvinerie, M. & Bousquet-Melou, A. (2002) Intestinal secretion is a major route for parent ivermectin elimination in the rat. Drug Metabolism and Disposition, 30, 626-630.
18. Lespine, A., Roulet, A., Dupuy, J., Pineau, T. & Alvinerie, M. (2003) Role of the P-glycoprotein in the cellular efflux of macrocyclic lactones: influence of interfering agents. Journal of Veterinary Pharmacology and Therapeutics, 26, 82-307.
19. Lifschitz, A., Virkel, G., Sallovitz, J., Imperiale, F., Pis, A. & Lanusse, C. (2002) Loperamide-induced enhancement of moxidectin availability in cattle. Journal of Veterinary Pharmacology and Therapeutics, 25, 111-120.
20. Mejia, M.E., Fernandez Igartua, B.M., Schmidt, E.E. & Cabaret, J. (2003) Multispecies and multiple anthelmintic resistance on cattle nematodes in a farm in Argentina: the beginning of high resistance? Veterinary Research, 34, 461-467.
21. Molento, M.B. & Prichard, R.K. (1999) Effects of the multidrug-resistance-reversing agents verapamil and CL 347,099 on the efficacy of ivermectin or moxidectin against unselected and drug-selected strains of Haemonchus contortus in jirds (Meriones unguiculatus). Parasitology Research, 85, 1007-1011.
22. Peregrine, A.S. & Mamman, M. (1993) Pharmacology of diminazene: a review. Acta Tropica, 54, 185-203.
23. Pyun, H.-J., Fardis, M., Tario, J., Yang, C.Y., Ruckman, J., Henninger, D., Jin, H. & Kim, C.U. (2004) Investigation of novel fumagillin analogues as angiogenesis inhibitors. Bioorganic & Medicinal Chemistry Letters, 14, 91-94.
24. Roulet, A., Puel, O., Gesta, S., Lepage, J.F., Drag, M., Soll, M., Alvinerie, M. & Pineau, T. (2003) MDR1-deficient genotype in Collie dogs hypersensitive to the P-glycoprotein substrate ivermectin. European Journal of Pharmacology, 460, 85-91.
25. Schinkel, A.H., Smit, J.J., van Tellingen, O., Beijnen, J.H., Wagenaar, E., van Deemter, L., Mol, C.A., van der Valk, M.A., Robanus-Maandag, E.C., te Riele, H.P., Berns, A.J.M. & Borst, P. (1994) Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the bloodbrain barrier and to increased sensitivity to drugs. Cell, 77, 491-502.
26. Schinkel, A.H., Wagenaar, E., van Deemter, L., Mol, C.A. & Borst, P. (1995) Absence of the mdr1a P-glycoprotein in mice affects tissue distribution and pharmacokinetics of dexamethasone, digoxin, and cyclosporin A. The Journal of Clinical Investigation, 96, 1698-1705.
27. de Silva, N., Guyatt, H. & Bundy, D. (1997) Anthelmintics. A comparative review of their clinical pharmacology. Drugs, 53, 769-788.
28. Smith, P.K., Krohn, R.I., Hermanson, G.T., Mallia, A.K., Gartner, F.H., Provenzano, M.D., Fujimoto, E.K., Goeke, N.M., Olson, B.J. & Klenk, D.C. (1985) Measurement of protein using bicinchoninic acid. Analytical Biochemistry, 150, 76-85.
29. Waller, P.J. (1997) Anthelmintic resistance. Veterinary Parasitology, 72, 391-412.
30. Xu, M., Molento, M., Blackhall, W., Ribeiro, P., Beech, R. & Prichard, R. (1998) Ivermectin resistance in nematodes may be caused by alteration of P-glycoprotein homolog. Molecular and Biochemical Parasitology, 91, 327-335.